U.S. Airlines Stock News

Bicara Therapeutics (BCAX) is reshaping its executive team around the potential commercialization of its lead cancer therapy, ficerafusp alfa, with a planned CEO transition and new CFO, COO, and legal leadership. See our latest analysis for Bicara Therapeutics. Bicara Therapeutics’ recent leadership reshuffle and shelf registration have arrived alongside a 1-day share price return of 2.72% to $24.94, after a 7-day share price return that declined 10.06% and a year-to-date share price return...

Strive stock has had a very weak year, with the share price down about 84.2% over the past 12 months, while the latest valuation checks send a mixed message that includes an undervalued read on market multiples but a low overall value score. Over the last year, Strive has declined 84.2%, which puts recent short term gains into the context of a much larger drawdown. For Strive, any improvement in converting revenue into dependable cash flow can support the current share price, while pressure...

H World Group stock slipped about 1.5% today, even though the earnings story pointed in the opposite emotional direction. You had a hotel operator already trading on a trailing P/E below broader hospitality peers. Then it delivered Q2 revenue of RMB 7,121m with adjusted net income of roughly RMB 1,700m and a wider adjusted EBITDA margin of 38.3%. The market treated this like a mild headache. The numbers looked more like a company quietly tightening its profit engine. Is H World Group trading...

Flexsteel Industries just saw its stock jump 8.9% to US$77.16, and the move was not driven by sentiment alone. Furniture investors went in expecting cautious guidance and modest profit, yet the headline from this quarter is margin power. Q4 revenue landed at about US$115.4m while basic earnings per share reached roughly US$2.82, capping a year in which net profit margin improved meaningfully and record trailing earnings met a still modest 12.5x P/E. The contrast between a cautious earnings...

UnitedHealth Group (NYSE: UNH) faces a new shareholder lawsuit alleging it ignored governance and cybersecurity risks tied to major Medicare fraud and a historic healthcare data breach. The complaint claims internal audits were shut down and an acquisition was rushed, which investors say contributed to what they describe as the largest healthcare data breach in U.S. history. The filing argues that UnitedHealth Group failed to maintain adequate internal controls, exposing the company to...

Chemed Corporation recently declared a quarterly cash dividend of US$0.70 per share, paid on September 3, 2026, to shareholders of record as of August 17, 2026, representing a 10‑cent increase over the June payout and marking its 221st consecutive quarterly dividend in 55 years as a public company. This long-running pattern of uninterrupted quarterly dividends, alongside a recent 17% increase, underlines how consistently Chemed has prioritized direct cash returns to shareholders. With this...

Why Sana Biotechnology’s Latest Earnings Matter For Investors Sana Biotechnology (SANA) recently reported second quarter and half year 2026 results, showing narrower net losses and lower basic loss per share compared with the same periods a year earlier. The company recorded a second quarter net loss of US$63.64 million and basic loss per share from continuing operations of US$0.22. For the six month period, net loss was US$110.85 million with basic loss per share of US$0.39. See our latest...

BitFuFu stock closed flat at US$1.29 after Q2, which suggests the market has not made up its mind. The headline is a tug of war between a reported net loss of US$20.6 million and an operating picture that looks far less bleak once fair value swings on Bitcoin are stripped out. For a Bitcoin miner, power cost and hashrate efficiency matter more than headline revenue. BitFuFu leaned into that by keeping fleet efficiency competitive and driving electricity at its Oklahoma site to about US$0.03...

Zenas BioPharma (ZBIO) is back in focus after second quarter 2026 results showed revenue of US$1 million alongside a net loss of US$111.46 million, paired with several senior leadership changes. See our latest analysis for Zenas BioPharma. At a share price of US$31.91, Zenas BioPharma has seen a 90 day share price return of 63.14%, while the year to date share price return is down 7.51% and the 1 year total shareholder return is 101.32%. This suggests recent momentum has picked up even as the...

Camtek guidance and Q2 results put recent stock move in focus Camtek (NasdaqGM:CAMT) has drawn fresh attention after record second quarter revenue tied to Advanced Packaging for AI uses, rapid order intake above US$600 million year to date, and upbeat third quarter guidance. See our latest analysis for Camtek. Camtek's recent Q2 update and strong third quarter revenue guidance appear to have fed into building momentum, with a 1‑month share price return of 17.55% and a year to date share price...

Northrop Grumman (NYSE:NOC) and Kratos Defense & Security Solutions received a U.S. Marine Corps contract to develop the Missionized Valkyrie Air Vehicle for the MUX TACAIR program. The Missionized Valkyrie will use Northrop Grumman’s mission kit and Open Architecture Autonomy Software for unmanned tactical aviation. The award expands Northrop Grumman’s role in unmanned systems for the Marine Air-Ground Task Force. Consider using this news as a starting point to review other defense and...

CDW (CDW) has drawn fresh investor attention after reporting second quarter 2026 results, including sales of US$6,572.2m and net income of US$274.4m, along with a declared quarterly dividend of US$0.630 per share. See our latest analysis for CDW. At a share price of US$134.97, CDW has recently seen a 90 day share price return of 27.08%, while the 1 year total shareholder return declined 17.90%. This suggests that recent momentum contrasts with weaker longer term outcomes. If CDW’s recent move...

Array Digital Infrastructure stock has delivered a 141.6% total return over the past 5 years, yet current checks on its valuation paint a more balanced picture rather than a clear bargain or an obvious overpricing. A 141.6% return over 5 years suggests Array Digital Infrastructure has already rewarded long term holders, which raises the bar for future returns from today's price. The key support for the valuation is whether the business can keep converting growth into durable cash flows. Any...

City Holding (CHCO) has drawn investor attention after recent share price moves, with the stock last closing at $146.22. This follows a month of gains and a stronger performance over the past three months. See our latest analysis for City Holding. Over a longer stretch, City Holding has seen a 30 day share price return of 7.70% and a 90 day share price return of 18.03%, while its 5 year total shareholder return of 115.28% shows how gains have compounded over time. If you are looking beyond...

Cheniere Energy, Inc. recently reported second-quarter 2026 results showing revenue of US$5,732 million and net income of US$3,068 million, while also lifting full-year 2026 net income guidance to US$1.60–2.00 billion and nudging up its LNG production forecast to 53–54 million tonnes. The company also disclosed that it has repurchased a cumulative 56,641,068 shares, or 24.1% of its share count, since 2019 for about US$9.27 billion, underscoring an ongoing commitment to returning capital...

WisdomTree stock has delivered very strong returns over the past five years, yet the current valuation checks suggest the shares are pricing in a lot of good news already rather than offering an obvious bargain. WisdomTree has returned 291.6% over the past five years, which puts extra focus on whether recent gains are now running ahead of fundamentals. Robust asset inflows and growth in assets under management can support higher earnings expectations, while any slowdown in demand for key...

Janux Therapeutics (JANX) stock is in focus after the company reported second quarter 2026 results, with net loss narrowing to US$21.97 million and basic loss per share from continuing operations at US$0.35. See our latest analysis for Janux Therapeutics. The latest earnings update appears to be feeding into a shift in how investors view Janux Therapeutics, with the share price at US$16.26 and a 90 day share price return of 17.74%, alongside a 3 year total shareholder return of 43.77% that...

Fidelity National Information Services (FIS) is back in focus after reporting sharply improved second quarter and year to date earnings, alongside the global rollout of its Digital One Commercial banking platform into the APAC region. See our latest analysis for Fidelity National Information Services. Despite the stronger earnings and the APAC rollout of Digital One Commercial, Fidelity National Information Services’ share price has come under pressure, with a year to date share price return...

Q2 earnings highlight a wider net loss but improved per share figures Avalo Therapeutics (AVTX) reported second quarter and first half 2026 results, with higher net losses than a year earlier. Loss per share figures improved, which gives investors a mixed picture to assess. See our latest analysis for Avalo Therapeutics. Avalo Therapeutics shares trade at US$19.71 after a recent 20.99% 90 day share price return and a 121.59% 1 year total shareholder return, although the 5 year total...

WESCO International recently reported its Q2 2026 results, with revenue rising 13% year on year to US$6.67 billion and adjusted EPS reaching US$4.57, both ahead of analysts’ expectations. The standout Communications & Security Solutions segment delivered 18.4% revenue growth and a record 10.2% EBITDA margin, underscoring the company’s momentum in higher-margin solutions offerings. With these results highlighting accelerating momentum in Communications & Security Solutions, we’ll examine how...

Oil prices are on the move as Middle East risks and rising global bond yields pull money toward safety and away from parts of the stock market. That mix can reshape how investors view large, global energy producers, from dividends to balance sheet strength. This article explains how the latest headlines relate to your portfolio, then profiles 3 stocks from our Global Integrated Oil & Gas and Energy Producers screener that appear especially exposed to these developments. The stocks covered in...

Earlier this year, Brunswick Corporation held a New York Media Day where it showcased its latest marine products and technologies, including autonomous docking via AutoCaptain, new electric propulsion systems, and advanced navigation and connectivity solutions under its ACES (autonomy, connectivity, electrification, shared usage) strategy. By highlighting concrete innovations like autonomous docking and integrated electric power and battery systems, Brunswick underscored how technology is...

Yelp Inc. recently reported its second-quarter 2026 results, with revenue rising to US$375.52 million while net income and earnings per share fell year over year, and it narrowed full-year 2026 net revenue guidance to between US$1.46 billion and US$1.47 billion. A few days later, Yelp also filed a US$52.58 million shelf registration for 2,100,000 common shares tied to an employee stock ownership plan, signaling ongoing use of equity-based compensation alongside its updated earnings...

Why RLJ Lodging Trust Stock Is Back in Focus After Q2 Earnings RLJ Lodging Trust (RLJ) is drawing attention after reporting second quarter results that showed higher sales and net income than a year earlier, followed by an updated full year earnings outlook. See our latest analysis for RLJ Lodging Trust. At a share price of $11.19, RLJ Lodging Trust has seen a 17.91% 90 day share price return and a 46.27% year to date share price return, while the 1 year total shareholder return of 62.47%...